CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them.

The source combined preclinical and clinical reports

The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal behavior involving one drug is not a clinical outcome involving another. The compound, experimental model and measured behavior must stay attached to the finding.

Reduced withdrawal is not the same as reduced drug seeking

A change in selected physical signs answers a different question from motivation to obtain a drug or sustained abstinence. Similarly, a reinforcement result does not by itself establish durable recovery in patients. These distinctions explain why several types of outcomes are necessary.

Mechanisms do not substitute for efficacy trials

The authors discussed multiple neurotransmitter systems and neurogenesis as possible contributors. A broad mechanistic rationale is valuable for choosing research questions, but it cannot identify a proven clinical regimen. The review does not establish that ordinary retail CBD products treat every substance-use disorder.

Interpreting the evidence

A treatment claim should name the drug involved, population, endpoint and duration. The review supplies an organizing framework for research potential. It does not justify translating fewer animal withdrawal signs directly into a claim of human addiction treatment.

Related reading: interpreting cannabis tolerance claims.

Research reference

Francisco Navarrete; María Salud García-Gutiérrez; Ani Gasparyan; Amaya Austrich-Olivares; Jorge Manzanares (2021). Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders. Frontiers in Pharmacology. doi:10.3389/fphar.2021.626010.

This analysis draws on the supplied review’s abstract and introductory material.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

A review published in 2020 graded psychiatric evidence from studies of CBD and CBD-containing nabiximols. Its recommendation labels should not be quoted as though every underlying intervention was purified CBD or every study was randomized. The included designs ranged widely The review identified 23 relevant studies spanning case reports, case…

Spread the love

Read Article: A Psychiatric CBD Review’s Recommendation Grades Included Both CBD and THC-Containing Nabiximols

CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

A 2021 ocular CBD review brought together in-vitro and in-vivo research, proposed molecular targets and possible therapeutic applications. This evidence maps a development pathway; it does not establish that CBD products are effective eye treatments. The experimental system belongs in the conclusion A cellular result can identify a target or…

Spread the love

Read Article: CBD Eye Research: Molecular Targets and Clinical Ocular Treatment Are Different Evidence Levels

CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

A 2021 review evaluated CBD research on reinforcing, motivational and withdrawal-related drug effects. These outcomes can inform substance-use-disorder research, but an improvement in one cannot establish successful treatment across all of them. The source combined preclinical and clinical reports The review covered alcohol, opioids, cannabinoids, nicotine and psychostimulants. An animal…

Spread the love

Read Article: CBD Addiction Research Measures Reinforcement, Motivation and Withdrawal as Different Outcomes

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us